Zydus Life shares rise 2% after USFDA nod for Eluxadoline tablets
Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 ...
The Financial Express19m
Infosys plunges 16% in 2025: 5 key factors investors need to know ahead of Q4 earnings
Explore 5 key factors affecting Infosys shares as Q4 earnings and possible dividend announcement approach. Stay informed!
Markets rally in early trade tracking sharp gains in global peers, buying in bank stocks
Sensex and Nifty rebound in early trade, IndusInd Bank gains, global markets rally, FIIs offload equities, macroeconomic ...
Sensex climbs 500 pts tracking gains in banking stocks, Asian peers; Nifty above 22,500
Indian benchmark indices Sensex and Nifty started the day on a positive note, fueled by gains in banking, financial, and auto ...